Corpus ID: 8639780

Androgens in serum and the risk of prostate cancer: a nested case-control study from the Janus serum bank in Norway.

@article{Vatten1997AndrogensIS,
  title={Androgens in serum and the risk of prostate cancer: a nested case-control study from the Janus serum bank in Norway.},
  author={L. Vatten and G. Ursin and R. Ross and F. Stanczyk and R. Lobo and S. Harvei and E. Jellum},
  journal={Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology},
  year={1997},
  volume={6 11},
  pages={
          967-9
        }
}
  • L. Vatten, G. Ursin, +4 authors E. Jellum
  • Published 1997
  • Medicine
  • Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
  • We tested the hypothesis that serum levels of testosterone (T), dihydrotestosterone (DHT), and the DHT metabolite 3 alpha,17 beta-androstanediol glucuronide are positively associated with the risk of prostate cancer. This nested case-control study was based on the cohort of men who donated blood to the Janus serum bank at Oslo University Hospital (Oslo, Norway) between 1973 and 1994. Cancer incidence was ascertained through linkage with the Norwegian Cancer Registry. The study included sera… CONTINUE READING

    Paper Mentions

    OBSERVATIONAL CLINICAL TRIAL
    Although compelling evidence from laboratory studies suggests that androgens play a major role in prostate carcinogenesis, epidemiologic studies in humans (almost exclusively… Expand
    ConditionsProstate
    Circulating steroid hormones in prostate carcinogenesis. Part 1 - Androgens.

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 21 REFERENCES